A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma
Authors:
Open Access
- 27 May 2021
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 21 (1) , 1-11
Abstract
Background: Lung cancer is one of the most lethal and most prevalent malignant tumors worldwide, and lung squamous cell carcinoma (LUSC) is one of the major histological subtypes. Although numerous biomarkers have been found to be associated with prognosis in LUSC, the prediction effect of a single gene biomarker is insufficient, especially for glycolysis-related genes. Therefore, we aimed to develop a novel glycolysis-related gene signature to predict survival in patients with LUSC.Methods: The mRNA expression files and LUSC clinical information were obtained from The Cancer Genome Atlas (TCGA) dataset.Results: Based on Gene Set Enrichment Analysis (GSEA), we found 5 glycolysis-related gene sets that were significantly enriched in LUSC tissues. Univariate and multivariate Cox proportional regression models were performed to choose prognostic-related gene signatures. Based on a Cox proportional regression model, a risk score for a three-gene signature (HKDC1, ALDH7A1, and MDH1) was established to divide patients into high-risk and low-risk subgroups. Multivariate Cox regression analysis indicated that the risk score for this three-gene signature can be used as an independent prognostic indicator in LUSC. Additionally, based on the cBioPortal database, the rate of genomic alterations in the HKDC1, ALDH7A1, and MDH1 genes were 1.9, 1.1, and 5% in LUSC patients, respectively.Conclusion: A glycolysis-based three-gene signature could serve as a novel biomarker in predicting the prognosis of patients with LUSC and it also provides additional gene targets that can be used to cure LUSC patients.Keywords
All Related Versions
Funding Information
- Zunyi Municipal Science and Technology Bureau (Zunshi Kehe (2015) No.17)
This publication has 37 references indexed in Scilit:
- ALDH7A1 Expression is Associated with Recurrence in Patients with Surgically Resected Non-Small-Cell Lung CarcinomaFuture Oncology, 2013
- Comprehensive genomic characterization of squamous cell lung cancersNature, 2012
- FoxQ1 Overexpression Influences Poor Prognosis in Non-Small Cell Lung Cancer, Associates with the Phenomenon of EMTPLOS ONE, 2012
- Aldehyde dehydrogenases and cell proliferationFree Radical Biology and Medicine, 2012
- Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell ProliferationAnnual Review of Cell and Developmental Biology, 2011
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Otto Warburg's contributions to current concepts of cancer metabolismNature Reviews Cancer, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Aldehyde Dehydrogenase Activity of Breast Cancer Stem Cells Is Primarily Due To Isoform ALDH1A3 and Its Expression Is Predictive of MetastasisStem Cells, 2010
- Molecular evolution of the vertebrate hexokinase gene family: Identification of a conserved fifth vertebrate hexokinase geneComparative Biochemistry and Physiology Part D: Genomics and Proteomics, 2008